AUTHORINDEX

June 1, 1996

Abrahams, P. J., 2621Abreu-Goris, M., 2556Aerssens, J., 2655Akizawa, T., 2535Alder, H., 2472Amaya, H., 2671Amos, C. I., 2596Antalis, T. M., 2510Arwert, F., 2621Asami, S., 2546

Baens, M., 2655Baffa, R., 2472Bal, S., 2662Barrett, J. C., 2539Battaglia, M., 2566Beck, W. T., 2573Bedi, G. C., 2484Bell, D. A., 2501Benetatos, C. A., 2584Berkowitz, R. S., 2501Bertagnolli, M. M., 2556Bertolini, F., 2566Bicknell,R.,2515Bienstock, R. J., 2539Boege, F., 2573Boolbol, S. K., 2556Borg, A., 2497Bova, 0. S., 2527Brien, S., 2475Brock, P., 2655

Cairns, P., 2527Califano, J., 2488Casero, R. A., Jr., 2527Cavanagh, L. L., 2607Chadburn, A., 2556Chakraborty,N.G.,2479Chang, A. E., 2677Chapman, A. E., 2584Chen, W., 2616Chen, Z-P., 2475Chinnadurai, G., 2506Chiodoni, C., 2531Cho, K. R., 2527Chun, S-B., 2662Chung, K-C., 2662Clayman, G., 2488, 2519Collins, J. M., 2677Colombo, M. P., 2531Connors, M. S., 2550Corio, R., 2488Corletto, V., 2472Cornelissen-Steijger, P. D. M., 2621Corsini, C., 2566Cranston, D., 2515Croce, C. M., 2472

Dannenberg, A. J., 2556Darden, T., 2539Darnowski, J. W., 2522Davide, J. P., 2626Davol, P. A., 2522DeCosse, J. J., 2556DeRemer, S., 2677Dexter, D. W., 2584Dickinson, J. L., 2510D'Sa-Eipper, C., 2506

Ellem, K. A. 0., 2510Ensminger, W. D., 2677Ergin, M. T., 2479

Fan,Y.,2519Felton, J. S., 2550FOlsch, U. R., 2641Frackelton, A. R., Jr., 2522Frankel, A. E., 2590Fuggle, S., 2515Fujimoto, K., 2666Fujioka, A., 2602Fukushima, M., 2602

Gabrielli, B. G., 2510Gabrielson, E., 2484GobI, A., 2561Goulette, F. A., 2522Greenberg, B., 2488Griffin, C. A., 2468Guo, X. J., 2556

Ha, T-Y., 2662Hahn, S. A., 2527HAkansson, S., 2497Halliday, G. M., 2607Harris, A. L., 2515Haston, C. K., 2596Hawkins, A. L., 2468Hay, N., 2506Hedrick, L., 2527Hirano, 1., 2546Hittelman, W. N., 2519Hong, W. K., 2519Horiuchi, T., 2671Hou, X., 2616Houweling, A., 2621Howley, P. M., 2649Hruban, R. H., 2527Hu, X., 2479Hudes, 0. R., 2584Huebner, K., 2472Huibregtse, J. M., 2649

Iki, M., 2671Im, S-Y., 2662lngvar, C., 2497Isaacs, W. B., 2527Itoh, H., 2546Itoh, M., 2535

Janson, E. T., 2561Johannsson, 0., 2497Johansson, U., 2497Jones, P. A., 2463

Kälkner,K. M., 2561Kang, H-S., 2662Kasai, H., 2546Kern, S. E., 2527Kim, J-W., 2662Kim, S. K., 2519King, T. M., 2596Kinoshita, T., 2535Kinsella, T. J., 2677Klecker, R. W., 2677Knol, J. A., 2677Ko, H-M., 2662Ko, Y-S., 2662Koch, W., 2484, 2488Kohl, N. E., 2626

Kurtzman, S. H., 2479Kusumoto, H., 2573

Lawrence, T. S., 2677Lazzari, L., 2566Lebowitz, P. F., 2626Lee, D., 2488Lee, H. B., 2662Lee, H-K., 2662Lee, Y-B., 2662Li, J. J., 2616Li, S. A., 2616Lipkin, M. L., 2556Lotan, R., 2519Loughridge,N.S.,2501

Maki,C.G., 2649Malapetsa, A., 2475Malfaui, M. A., 2550Mao, L., 2519Marcantonio, D., 2475Martucci, C., 2556Marynen, P., 2655MAsbhck,A., 2497Mathupala, S. P., 2468Matsumura, M., 2671Mauthe, R. J., 2550Mecucci, C., 2655Melani, C., 2531Meltzer, P. S., 2527Menko, F. H., 2621Milligan, A., 2510Mo, Y-Y., 2633Mohr, G., 2475Mok, S. C., 2501Mukherji, B., 2479Muraoka, R., 2671Muto, M. G., 2501

Nadasdy, G. M., 2527Nakano, K., 2602Nawroz, H., 2488, 2527Negrini, M., 2472Newmark, H. L., 2556

Oberg, K., 2561O'Brien, T., 2515Oh, S-J., 2662Okabe, H., 2602Olsson, H., 2497Oyama, K., 2602Oyasu, R., 2666

Panasci, L. C., 2475Papadimitrakopoulou,V.,2519

Parenza, M., 2531Pedersen,L.,2539

Pedersen, P. L., 2468Peeters, P., 2655Piantadosi, S., 2488Pierotti, M. A., 2472Pilotti, S., 2472Pinedo, H. M., 2621Poisson, L., 2590Post, K. D., 2493Prendergast, G. C., 2626

Rademaker, A., 2666Raimondi, S. C., 2573Ramonetti, J. T., 2556Ranganathan, S., 2584

Re, 0. 0., 2590Rempel, A., 2468Reynolds, A. B., 2633Robertson, J. M., 2677Rodgers, Q. E., 2573

Saito, H., 2602Satake,H., 2602

Sato, H., 2535Schafer, H., 2641Schmidt, W. E., 2641Schutte, M., 2527Seiki, M., 2535Shimomatsuya, T., 2671Shirasaka, T., 2602Sidransky,D.,2484,2488,2527Siegel, E. G., 2641Soligo, D., 2566Sozzi, G., 2472Sporn, J. R., 2479Spreafico, F., 2531Stetson, P. L., 2677Stoppacciaro, A., 2531Subramanian, T., 2506Sugamura, K., 2590

Takechi, T., 2602Takeda, S., 2602Takino, T., 2535Tanaka, Y., 2666Tangir, J., 2501Tanigawa, N., 2671Terleth, C., 2621Tew, K. D., 2584Thalmeier, K., 2566Tomioka, Y., 2546Tornielli, S., 2472Trauzold, A., 2641Travis, E. L., 2596

Uchida, J., 2602Uhlmann, E. J., 2506Unemi, N., 2602

Vagliani, M., 2531Van den Berghe, H., 2655van der Eb, A. J., 2621van der Riet, P., 2488Veronese, M. L., 2472

Wagner, A. J., 2506Walker, S. C., 2677Wang,X.Q.,2510Waters, C., 2590Wechsler-Reya, R., 2626Weinstein, C. L., 2527Welch, W. R., 2501Westerdahi, J., 2497Westra, W., 2484, 2488Willingham, M. C., 2590Wiseman, R., 2539Wlodarska, I., 2655Woloschak, M., 2493

Xiao, J., 2493

Yamaguchi, R., 2546Yang, Z., 2677Yu, A., 2493

Zibera, C., 2566

2682

BENEFITS OF MEMBERSHIP Committee which receives applications for corresponding membership.Candidates will be notified according to the following schedule:

Receipt of Application

in AACR Office ______________January 1May 1September 1

A complete application consists of the following material:1. 6 copies of the form on the opposite side of this page, with all requested

information provided.2. 5 copies of the candidate's most current curriculum vitae and bibliog

raphy.3. 5 copies of a letter of recommendation from a nominator who is an

active, corresponding, emeritus, or honorary member of the AACR (atleast one copy must be a signed, original letter). This letter shoulddescribe the candidate's achievements in laboratory research, clinicalinvestigations, or epidemiological research, and it should affirm thatthis research adheres to accepted ethical scientific standards. —OR—Thenominator may supply the responses requested at the bottom of theapplication form in the section entitled “STATEMENTOF SUPPORT―(at least one copy of the form must be the signed original).

4. 5 copies of a letter of recommendation as described in Item 3 abovefrom a seconder who is an active, corresponding, emeritus, or honorarymember of the AACR (at least one copy must be a signed, originalletter). —OR—The seconder may supply the responses requested at thebottom of the application form in the section entitled “STATEMENT OFSUPPORT―(at least one copy of the form must be the signed original).

5. 5 reprints of each of two publications on which the candidate appears asauthor. As noted above, evidence of patents developed by the candidatemay be submitted in lieu of one or both of the publications. If submittingpatents, supply patent number and year awarded.

All material should be collated into five complete sets with the originalapplication form as a covering document and sent to the address givenbelow. Questions regarding procedures for membership application mayalso be directed to the following address:

American Association for Cancer ResearchPublic Ledger Building, Suite 816

150 S. Independence Mall WestPhiladelphia, PA 19106-3483

Phone: 215/440-9300FAX: 215/440-9313

E-mail: aacr@aol.com

RESPONSIBILITIES OF MEMBERSHIPCandidates should be aware of the following responsibilities of mem

bership in the AACR. Active members must pay annual dues. In 1996annual dues for active members are $160, $95 of which is designated forAACR journal subscriptions. Newly elected members of the AACR whohave already purchased subscriptions to Cancer Research, Clinical Cancer Research, Cell Growth & Differentiation, or Cancer Epidemiology,Biomarkers & Prevention at the higher, nonmember rates will receivereimbursement of the unused portion of those subscriptions once their firstyear's membership dues are paid in full.

Corresponding members are required to pay dues ($80 in 1996) andmay, if they wish, subscribe to Cancer Research, Clinical Cancer Research, Cell Growth & DWerentiation, or Cancer Epidemiology, Biomarkers & Prevention at reduced member rates.

Applicants elected in March will be responsible for payment of thatyear's dues; applicants elected in July and November will pay dues for thefollowing year. Applicants elected in March and July will be eligible tosponsor an abstract for the next annual meeting. Every effort will be made

to afford the same opportunity to applicants elected in November.

Margaret Foti, Ph.D.Executive Director

The American Association for Cancer Research (AACR), a scientificsociety of over 11,000 laboratory and clinical cancer researchers, wasfounded in 1907 to facilitate communication and dissemination of knowledge among scientists and others dedicated to the cancer problem; tofoster research in cancer and related biomedical sciences; to encourage thepresentation and discussion of new and important observations in thefield; to foster public education, science education, and training; and toadvance the understanding of cancer etiology, prevention, diagnosis, andtreatment throughout the world.

Members of the AACR enjoy the following benefits:

1. the privilege of sponsoring a proffered paper (abstract) for consideration for presentation at the AACR annual meeting;

2. an advance copy of the Program and Proceedings of the AmericanAssociationfor Cancer Research that contains over 4,000 abstracts ofproffered papers presented at the annual meeting;

3. reduced registration rates at annual meetings;4. priority notice of small, focussed meetings in the AACR's exciting

series of Special Conferences in Cancer Research;5. substantially reduced registration rates for Special Conferences;6. opportunities for participation in AACR meetings in North America

and abroad with other scientific societies around the world;7. receipt of AACR Newsletters and other important announcements;8. early notification of and reduced rates for participation in the AACR

Employment Register;9. an up-to-date Membership Directory of over 11,000 member re

searchers in the cancer field;10. the professional benefits of the AACR's public education activities

concerning funding for cancer research and press coverage of thelatest research findings;

11. the opportunity to participate in three Summer Workshops that fosterknowledge in the cancer field for young investigators;

12. the facilitation of informal scientific exchange with leading researchera in the cancer field; and

13. many more ongoing benefits.

QUALIFICATIONSFORMEMBERSHIPActive membership in the AACR is open to investigators who live in

the Americas. Individuals who have conducted two years of researchresulting in peer-reviewed publications relevant to cancer, or who havemade substantial contributions to cancer research in an administrative oreducational capacity, are eligible. If a candidate has conducted research inan area of biomedical science related to cancer, he or she will qualify formembership. Evidence of patents relevant to cancer research may besubmitted as qualifications for membership in lieu of peer-reviewedpublications.

Corresponding membership is open to persons who are not residentsof the Americas. The qualifications for corresponding membership are thesame as those indicated above for active membership. Visiting scientistsfrom outside the Americas who intend to return to their countries of originby the anticipated time of election should apply for corresponding membership. All other visiting scientists should apply for active membershipand transfer to corresponding status upon leaving the Americas.

Graduate and medical students, postdoctoral fellows, and physicians intraining who do not yet meet the above qualifications for active orcorresponding membership should apply for associate membership.Forms for associate membership are available from the AACR Office.

PROCEDURES FOR APPLICATION

There are three deadlines for the receipt of a membership application:January 1, May 1, and September 1 of each year. The MembershipCommittee will review all complete applications for active membershipthat have been received by these deadlines and will submit recommendations on each candidate to the Board of Directors which formally elects allmembers. The same procedure is followed by the Special Memberships

Notification of CandidateMarchJulyNovember

AMERICAN ASSOCIATION FOR CANCER RESEARCH

GUIDELINESFOR APPLICATIONFOR ACTIVE ANDCORRESPONDING MEMBERSHIP

(City) (State/Province)

TELEPHONE NUMBER:____________________________(Country)

(Postal Code)

FAXNUMBER:_________________________E-MAILNUMBER (CARRIER):

PRIMARY FIELD OF RESEARCH (Please check onlyone):Biochemistryand BiophysicsBiostatisticsCarcinogenesisBiology

and GeneticsInvestigationsEndocrinologyEpidemiologyimmunologyBiology andGeneticsPrecliical

Pharmacology andExperimental Therapeutics(Pleasespecify)ACADEMIC

DEGREES (Including where and whengranted)EXPERIENCE

SINCE HIGHEST DEGREE WAS GRANTED (Please list most recent first)

APPLICATION FOR ACTIVE OR CORRESPONDING MEMBERSHIP

PRESENT POSmONmuE:@

INSTITUTIONAL AFFILIATION:.

INSTITUTIONAL ADDRESS:_

DATE OF BIRTH:_________LAST FIRST M.I.

PUBLICATIONS(Reprintsof twopeer-reviewedarticlesonwhichthecandidateappearsasanauthormustaccompanythisapplication.Forthese two articles list the authors, title, journal, volume, inclusive pages, and year. Do not submit abstracts. if submitting patents, supply patentnumber and year awarded.)

CANDIDATENOMINATED BY*:

(Please print)

CANDIDATE IS APPLYING FOR (Check one): J ACTIVE

How long has the candidate worked in the field of cancer research? yearsWill the candidate make a long-term contribution to cancer research? ...Yes ...NoDoes the candidate's research adhere to accepted ethical standards? ...Yes NoI therefore recommend this candidate for membership in the AmericanAssociation for Cancer Research.

CANDIDATESECONDED BY*:.

0 CORRESPONDING MEMBERSHIP

How long has the candidate worked in the field of cancer research? yearsWill the candidate make a long-term contribution to cancer research? _Yes .NoDoes the candidate' s research adhere to accepted ethical standards? .Yes .NoI therefore recommend this candidate for membership in the AmericanAssociation for Cancer Research.

(Please print)

STATEMENT OF SUPPORTInstead of submitting letters of recommendation, either the nominator or the seconder or both may complete the following section:

DateSignature of nominator* Date Signature of seconder*

See Guidelines for Application on the reverse side of this form for further instructions.

*Both nominator and seconder must be active, corresponding, emeritus, or honorary members of the AACR.

(This form may be reproduced.) 1996

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.Public Ledger Building - Suite 816 - 150 S. Independence Mall West Philadelphia, PA 19106-3483

NAME OF CANDIDATE:.

one ofthese copies must carry the original signatures ofboth the candidateand the nominator. The application form may be submitted to the Association Office at any time.

After review of applications for associate membership, the ExecutiveDirector will notify candidates of their election or deferral within onemonth of the receipt of the application form. A check for one year's duespayment must accompany the application. Dues are currently $35 forassociate members residing in the Americas and $45 for residents of othercountries. This fee will be refunded to any candidate deemed to beineligible for associate membership. Checks should be in U.S. currency,made payable to AACR, Inc., and drawn on a U.S. bank. Send the threecopies of the application form and the $35 or $45 dues payment to:

American Association for Cancer ResearchPublic Ledger Building, Suite 816

150 S. Independence Mall WestPhiladelphia, PA 19106-3483

Phone:215/440-9300FAX: 215/440-9313

E-mail: aacr@aol.com

RESPONSIBILITWS OF MEMBERSHIP

Associate members must pay annual dues in an amount to be determined by the AACR Board of Directors. Dues for 1995 and 1996 havebeen set at $35 per year for residents of the Americas and $45 for residentsof other countries. If an application is submitted by August 31, theaccompanying dues payment will be credited to the current year. Candidates submitting applications between September 1 and December 31 mayindicate whether they wish their dues payments credited to the current orforthcoming year. Candidates should be aware, however, that associatemembers may sponsor an abstract for the annual meeting only if their duesfor the current year are paid. For example, an associate member submitting an abstract in November 1995 for the forthcoming annual meetingmust have paid dues for 1995. Any newly elected associate members ofthe AACR who have already purchased subscriptions to Cancer Research,Clinical Cancer Research, Cell Growth & Differentiation, or CancerEpidemiology, Biomarkers & Prevention at the higher, non.member ratewill receive a refund for the unused portion of that subscription uponreceipt of their payment for a member's subscription.

Each Fall the AACR will send to current associate members an invoicefor dues for the forthcoming year. Payment of this invoice must beaccompanied by a statement signed by the associate member's currentregistrar, dean, or department head, verifying the member's current academic status. The Association's By-Laws state that dues are payable foreach year in advance by January 1 of the year to which they should beapplied. An individual may be an associate member for a maximum offive years. Each year in which an individual pays dues will count as onefull year of associate membership. Thus, an associate member who paysdues for 1995 may retain associate membership until December 31, 1999.The Board of Directors may terminate the membership of an associatemember whose dues are in arrears for two years.

Margaret Foti,Ph.D.

Executive Director

AMERICAN ASSOCIATION FOR CANCER RESEARCH

@ GUIDELINESFOR APPLICATIONFOR ASSOCIATEMEMBERSHIP

QUALifICATIONS FOR MEMBERSHIP

Associate membership is open to graduate students, medical students,postdoctoral fellows, and physicians in training who are following acourse of study or who are working in a research program relevant tocancer. Scientists in training who already have a substantial record ofpublications may wish to apply for active or corresponding membershipwhich confers full benefits of membership.

BENEFITS OF MEMBERSHIP

The American Association for Cancer Research (AACR), a scientificsociety consisting of laboratory and clinical cancer researchers, wasfounded in 1907 to facilitate communication and dissemination of knowledge among scientists and others dedicated to the cancer problem; tofoster research in cancer and related biomedical sciences; to encouragepresentation and discussion of new and important observations in thefield; to foster public education, science education, and training; and toadvance the understanding of cancer etiology, prevention, diagnosis, andtreatment throughout the world. Associate members of the AACR enjoythe following benefits:

1. the privilege of sponsoring a proffered paper (abstract) for consideration for presentation at the AACR annual meeting provided that (a)the associate member is the presenter of the paper and (b) an active,corresponding, emeritus, or honorary member in good standing of theAACR also signs the abstract of the paper in support of the work. (Inthis instance, the member who cosigns the abstract does not lose hisor her own sponsorship privilege.);

2. an advance copy of the scientific Program and (if one has beenpurchased by the associate member) the Proceedings ofthe AmericanAssociationfor Cancer Research that contains over 4,000 abstracts ofproffered papers presented at the annual meeting;

3. the privilege ofregistering for the annual meeting at the low associatemember rate;

4. preferred access to the AACR Employment Register;5. optional subscriptions to the Association's high-quality journals Can

cer Research, Clinical Cancer Research, Cell Growth & Differentiation, and Cancer Epidemiology, Biomarkers & Prevention at reduced member rates;

6. priority notification of events in the AACR's series of special conferences on timely subjects in the field;

7. substantially reduced registration rates at special conferences;8. the receipt of AACR newsletters, meeting announcements, and an

up-to-date Membership Directory;9. the opportunity to participate in three Summer Workshops that foster

knowledge in the cancer field for young investigators; and10. the facilitation of informal scientific exchange with leading research

era in the cancer field.

PROCEDURES FOR APPLICATIONPersons wishing to apply for associate membership must use the

official application form on the reverse side of these instructions. Eachcandidate for associate membership must be nominated by an active,corresponding, emeritus, or honorary member in good standing of theAACR. Three completed copies of the form should be submitted; at least

APPLICATION FORASSOCIATEMEMBERSHIP . .@ INAME

OFCANDIDATE:______________________________________DATE OFBIRTH:_________LAST

INSTITUTIONALFIRSTM.I.AFFILIATION:__________________________________________________________INSTITUTIONAL

ADDRESS:(City)(State/Province)(Country)(Postal

Code)

TELEPHONE NUMBER:____________________________ FAX NUMBER:_________________________

PRESENT ACADEMIC STATUS/TITLE (Please check only one): E-MAIL NUMBER (CARRIER):_____Graduate Student @MedicalStudent

Physician in Training Postdoctoral Fellow

PRIMARY FIELD OF RESEARCH (Please check only one):Biochemistry and Biophysics Biostatistics Carcinogenesis

_____Cellular Biology and Genetics _____Clinical Investigations @EndocrinologyEpidemiology Immunology Molecular Biology and GeneticsPreclinical Pharmacology and Virology Other:_________________________________Experimental Therapeutics (Please specify)

ACADEMIC DEGREES (Please indicate degree(s) acquired to date along with the name of the academic institution and date of receipt. Provideinformation on degree currently being sought and the anticipated date of completion of this degree program.)

RELEVANT RESEARCH EXPERIENCE NOT RELATED TO COURSE WORK (Please list most recent first.)

PUBLICATIONS (List the authors, title, journal, volume, inclusive pages, and year of any article in a peer-reviewed journal on which thecandidate appears as an author. Do not list abstracts. Continue on a separate sheet, if necessary.)

CANDIDATE NOMINATED BY*:_________________________________________________________(Please print)

SIGNATURESI hereby apply for associate membership in the American Association for Cancer Research. I have read the instructions on the reverse side ofthis form, and I understand the privileges and responsibilities of this class of membership. I certify that the statements on this application aretrue.

Signature of Candidate:_________________________________________________________________ Date:___________________

I recommend this candidate for associate membership in the American Association for Cancer Research. To the best of my knowledge, thecandidate is qualified for this class of membership, and the statements on this application are true.

Signature of Nominator*:______________________________________________________________ ___________________

Submit three copies of this form. At least one copy must contain the original signatures of the candidate and the nominator. Enclose a checkin U.S. funds, made payable to AACR, Inc., and drawn on a U.S. bank for one year's dues. Dues are currently $35 for associate membersresiding in the Americas and $45 for residents of other countries.

Check one of the following boxes only if this form is being submitted between September 1 and December 31:The enclosed dues payment should be applied to the @1current @1forthcoming calendar year.

(NOTE: If dues are applied to the forthcoming year, membership will take effect on January 1, but the candidate will not be eligible to sponsoran abstract for presentation at the annual meeting in March on April of that year.) See Guidelines for Application on the reverse side of thisform for further instructions.

*Nominator must be active, corresponding, emeritus, or honorary member of the AACR.

(This form may be reproduced.) 1996

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.Public Ledger Building - Suite 816 - 150 5. Independence Mall West - Philadelphia, PA 19106-3483

Guidelinesfor SubmittingDisksto

AmericanAssociationfor Cancer Research Publications

The word processing packages that we prefer are as follows:

MacWrite WordPerfect (DOS, Windows,Microsoft Word (DOS, Windows, and Macintosh)

and Macintosh) XyWnte (DOS and Windows)

Also acceptable:

Ability Mass 11 SoloWriterAmiPro MS Windows Write SprintAMS-T@X MS Works StxAppleworks MS Works WP Mac SunWntekborT@X Multimate SymphonyArborlext Multimate Advantage TEXClarisWorks WP Nibia T@X78CPT 8000 Nisus (to ASCII file) Text EXecutiveCTOS Notewnter TexturesDiablo Obun Total WordDisplayWnte OfficeWriter TroffDuet PC WriteEinstein PFS First Choice VolkswnterEnable Professional Write VuWriterEXP Q&A Write Wang OISFinal Word Quark XPress Wang WPSFullWnte RagTime MS Works Wang WriterGemWord Plus (to ASCII file) Window WorksIBM Writing Assistant Rich Text Format Windows WriteInterleaf RSG (to ASCII file) WiziWordLATEX Signature WordstarLatex SLITEX Wordstar 2000Leading Edge SmartWhere WnteNowLotus Manuscript SmartWnte II XeroxLotus Write

Software packages that we are unable to translate:

FrameMaker Ready, Set, GoPageMaker Scientific Writer

Disks produced on IBM or IBM-compatible computers are preferred, but those produced on some Apple orWangcomputerscanalsobeconverted.Becauseof the filestructuresand internalcoding,wecannotacceptdisks createdon desktop publishingsystemsor thosecreatedon propnetarytypesettingsystems.Wealsocannotguaranteethat all specialcharacterscan be translated.Tabularand mathematicalmaterial,such asequations, will not be captured from the disk but will be rekeyed.

To expeditework andfor your own security,we do requirethat you submita hardcopy printoutof the diskfile. Thetablesand equationswill be keyedfrom this hardcopy. We also needto knowthe nameof the filetobeconverted,thetypeofhardware(e.g.,IBMPC)onwhichthefileswerecreated,theoperatingsystem(e.g.,DOS3.3),and the versionof the software(e.g.,WordPerfect5.1)usedto createthe file.

PLEASE FILL OUT ALL INFORMATION ON REVERSE SIDE AND SUBMIT THIS FORM WITH YOUR DISK.DISKSWILL NOT BE PROCESSEDWIThOUT THIS INFORMATION.

DISK SUBMISSION FORM

AACRjournalsare now usingpersonalcomputersto copyedit manuscriptsacceptedfor publication.Whensubmittinga revisedmanuscript,authorsareencouragedto submitanelectronicdiskof the paperalongwiththe requiredfour hard copy printouts.Diskswill ultimatelybe returnedto the authors.

I Seereverseforthewordprocessingpackagesthatcanbeaccepted.

File preparation

Pleasebesurethat thefileyousendisthe mostrecentversionof the manuscriptandthat it matchesthe mostrecentlysubmitted printed copy. The file shouldcontainall the parts of the manuscriptin one file. Mathematicalandtabularmaterial,however,will be processedin the traditionalmannerandmaybeexcludedfromthe disk file.

Note:AACRdoes not assumeresponsibilityfor errorsin conversionof customizedsoftware,newlyreleasedsoftware,or specialcharacters.

Pleaselabel the outside of the disk with the journal name, the first author's name, a partial title of themanuscript,andthe nameof the computerfile usedto accessthe manuscripton disk.To processyourdiskefficiently,we needthe following information.Pleasebe sureto provideALL the information.

Name used to access paper on disk: ___________________

Name of computer used (e.g., UBM/PS2):

Operating system and version (e.g., DOS 3.3):

Word processing program and version (e.g., WordPerfect 5.0):

[See reverse for acceptable programs.1

Manuscript number: _________________________________Firstauthor@_____________________________________Corresponding author cd different from first author):Telephone/FAX numbers: ____________________________

This form (both sides) may be reproduced.

FEBRUARY13-16, 1997GrowthFactors,Signaling,and CancerJointMeetingwithLorneCancerConference

Chairpersons: Antony Burgess, Parkville, Victoria,Australia; Robert J. Coffey, Nashville, TN;Ashley R. Dunn, Parkville, Victoria, Australia;Webster K. Cavenee, La Jolla, CA

Erskine House, Lorne, Victoria, Australia

FEBRUARY23-28, 1997Cell Signallngand Cancer Treatment

In Collaboration with British Association for CancerResearch, EORTC (PAMM Group), GermanCancer Society, and Austrian BiochemicalSociety

Chairpersons: Hans H. Grunicke, lnnsbruck,Austria; Garth Powis, Tucson, AZ; PaulWorkman, Macclesfield, England

Interalpen-Hotel Tyrol, Telfs-Buchen, Austria

MARCH7-12,1997Basic and ClinicalAspects of

Breast CancerChairpersons: J. Carl Barrett, Research Triangle

Park, NC; Karen S.H. Antman, New York, NY;Mary-Claire King, Seattle, WA

Keystone Resort, Keystone, CO

APRIL 12-16, 199788th Annual Meeting

Chairperson: Frederick P. Li, Boston, MAVice-Chairpersons: Clara Derber Bloomfield,

Buffalo, NY; Stephen H. Friend, Seattle, WASan Diego Convention Center, San Diego, CAAbstract Deadline: November 12, 1996

AACR members will receive brochures on theabove conferences as soon as they are available.Nonmembers should call or write:

American Association for Cancer ResearchPublic Ledger Building, Suite 816150 South Independence Mall WestPhiladelphia, PA 19106-3483215-440-9300 •215-440-9313 (FAX)E-Mail: aacr@aol.com

JUNE 8-12, 1996Inducible GenomicResponses

Chairpersons: William T. Beck, Chicago, IL; JohnA. Hickman, Manchester, England; Richard I.Monmoto, Evanston, IL

Skamania Lodge, Stevenson (Columbia RiverGorge), WA

OCTOBER2-6, 1996Novel Approachesin Blood and

Marrow TransplantationSecond Annual Meeting of the American Society

for Blood and Marrow TransplantationChairpersons: 0. Michael Colvin, Durham, NC;

Bruce R. Blazar, Minneapolis, MNHotel Del Coronado, San Diego, CA

OCTOBER6-9, 1996Carcinogenesisfrom Environmental

Pollution: Assessmentof Human Risksand Strategiesfor PreventionJointMeetingwithInternationalAgencyfor

Research on CancerChairpersons: Fredenca Perera, New York, NY;

Paul Kleihues, Lyon, FranceHotel Gellért,Budapest, Hungary

OCTOBER19-23, 1996ProgrammedCell Death

Chairperson: Stanley J. Korsmeyer, St. Louis, MOThe Sagamore, Bolton Landing (Lake George), NY

JANUARY 10-14, 1997Basic and ClinicalAspects of Lymphoma

Joint Meeting with the American Society of ClinicalOncology

Chairpersons: Joseph A. Bertino, New York, NY;James 0. Armitage, Omaha, NE

Stouffer Renaissance Esmeralda Resort, IndianWells (Palm Springs), CA

JANUARY17-21,1997Disrupted TranscriptionFactorsin Cancer

Chairpersons: Peter K. Vogt, La Jolla, CA; FrankJ. Rauscher Ill, Philadelphia, PA

Hotel Del Coronado, San Diego, CA

AMERICAN ASSOCIATION FOR CANCER RESEARCHSCIENTIFIC CONFERENCES

AACR SPECIAL CONFERENCE IN CANCER RESEARCH

ProgrammedCellDeath

October19-23,1996TheSagamore,BoltonLanding(LakeGeorge),NewYork

CONFERENCE CHAIRPERSONS

StanleyJ. KorsmeyerI St.Louis,MOShigekazuNagataI Osaka,Japan

AndrewH.WyllieI Edinburgh,Scotland

SCIENTIFICPROGRAM

KeynoteAddressMartinC.RaftI London,England

DevelopmentH.RObedHorvltzI Cambridge,MAHermann Stellar I Cambridge, MAStanleyJ. KorsmeyerI St.Louis,MO

OncogenesisDouglasHanahanI SanFrancisco,CAMInaJ. BlssellI Berkeley,CAEileen P. WhIte I Piscataway, NJGerardI.EvanI London,England

Death AntagonistsSuzanneCoryI Melbourne,AustraliaCraigB.ThompsonIChicago,ILLoisK.MillerI Athens,GA

Death SignalsShigekazuNagataI Osaka,JapanPeterKrammerI Heidelberg,GermanyDavidV.GoeddelI S.SanFrancisco,CAGeorgeD.YancopoulosI Tarrytown,NY

DeathEffectorsJunyingYuanI Chariestown,MADonaldW.NicholsonI Pointe-Claire-Dorval,Quebec,CanadaVishvaDixitI AnnArbor,MIArnoldH.GreenbergI Winnipeg,Manitoba,Canada

Survival SignalsAndrew H. Wyllie I Edinburgh, ScotlandTadatsugu Taniguchi / Tokyo, JapanKen-ichlAraII Tokoyo,Japan

ResistanceandTherapeuticsMichaelB.KastanI Baltimore,MDRichardN.KolesnlckI NewYork,NY

AdditIonalSpeakersto beAnnounced

Applicants are encouraged to submitabstracts for poster presentation.

Application deadline: August 2, 1996

InformationandApplicationFormsAmericanAssociationfor CancerResearchPublicLedgerBuilding,Suite816150 South IndependenceMallWestPhiladelphia,PA 19106-3483215-440-9300 215-440-9313 (FAX)E-mail: aacr@aol.com

1996 Sustaining Members

The American Association for Cancer Research is pleased to acknowledge its I 996 SustainingMembers. We are grateful for the generous support derived from this category of membership, which isopen to organizations that pay dues and make other significant contributions toward the purposes, activities,and overall mission of the Association. The AACR looks forward to a long and productive partnership withthe Major Sustaining Members and regular Sustaining Members listed below.

Major SustainingMembersAmgen

CIBA-GEIGYLimited

Genentech, Inc.

Glaxo Wellcome Oncology

Hoffmann-LaRocheInc.

RhOne-Poulenc Rorer

Sandoz PharmaceuticalsCorporationZENECA Pharmaceuticals

SustainingMembersBASF BioresearchCorporation

Bayer CorporationBerlex Biosciences,Inc.

Bnstol-Myers Squibb Pharmaceutical Research Institute

Coulter CorporationCYTOGENCorporation

The Du Pont Merck PharmaceuticalCompanyEli Lilly and CompanyGenetics Institute, Inc.

HoechstMarion RousselILEX Oncology

Janssen ResearchFoundationMerck & Co., Inc.

Oncor, Inc.

Ortho Biotech

Parke-DavisPharmaceuticalResearch,Warner-LambertCompanyThe Pezcoller Foundation

PfizerCentral ResearchPharmacia& Upjohn, Inc.

The Procter& GambleCompanySanofi Winthrop, Inc.

Schering-PloughResearchInstituteSearle

Taiho PharmaceuticalCo., Ltd.Varian Associates

Yamanouchi Pharmaceutical Co., Ltd.

2ND ANNUAL SCIENTIFIC MEETING OF THEAMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION

JOINT SPECIAL CONFERENCE WITH THEAMERICAN ASSOCIATION FOR CANCER RESEARCH

NovelApproachesinBloodandMarrowTransplantation

October2-6,1996HoteldelCoronado

SanDiego,CA

CONFERENCE CO-CHAIRPERSONS

Bruce R. BlazarI Minneapolis,MN 0. MichaelCoIvin I Durham,NC

PROGRAM COMMITTEE

Joseph R. Bertino I New York, NYBarbara E. Bierer I Boston,MARichard E. Champlin I Houston,TXNelson J. Chao I Stanford,CAConnie J. Eaves I Vancouver,BC, Canada

OliveraJ.Finn I Pittsburgh,PARonald E. Gress I Bethesda,MDHelen E. Heslop I Memphis,TNJohn H. Kersey I Minneapolis,MNKeith M. Sullivan I Seattle, WA

PLENARYSESSIONS

PharmacologicApproachestoReducingMalignancy

Joseph R. Bertino I New York, NYRobert B. Diasio I Birmingham,ALWilliamHyrniukI Stanford,CA0. MichaelColvinI Durham,NC

BiologicApproachestoReducingMalignancy

JohnH.KerseyI Minneapolis,MNMartinKastI Chicago,ILFatihM.UckunI Minneapolis,MNJohnR.MurphyI Boston,MAGlennDranoffI Boston,MAOliveraJ. FinnI Pittsburgh,PA

Optionsfor HematopoleticProgenitorCellSources

ChristopherJuttnerI PaloAlto,CAPeterM.LansdorpIVancouver,BC,CanadaJanNoltaI LosAngeles,CAPaulMartinI Seattle,WA

AllogeneicApproachesto ReducingMalignancyPost-BMT

BruceR.BiazarI Minneapolis,MNRonaldE.GressI Bethesda,MDRobertKorngoldI Philadelphia,PALeeM.NadlerI Boston,MA

Biologyof BreastCancerWilliamP.PetersI Durham,NCKarenS.H.AntmanI NewYork,NYJeffrey T. Holt I Nashville, TNDanielD.VonHoffI SanAntonio,TX

SCIENTIFICSUBCOMMITrEESANDCHAIRPERSONS

SolidTumorsEmilFrelIIII Boston,MAWilliamP.PetersI Durham,NC

LymphoidMalignanciesJeromeRftzI Boston,MAGordonL PhillipsI Lexington,KY

ExperimentalTherapeutics0. MichaelColvinI Durham,NCStanleyRiddeIlI Seattle,WA

GeneTherapyDonaldB.KohnI LosAngeles,CAMalcolmK.BrennerI Memphis,TN

WORKSHOPTITLESANDCHAIRPERSONS

TumorBiologyand ResidualDiseaseDetection

PaulM.SondelI Madison,WIJohnGribbenIBoston,MA

GrowthFactorsandSourcesofStemCells

JoanneKurtzbergI Durham,NCMalcolmA.S.MooreI NewYork,NY

GraftRejection/GVHD/GVLElsGoulmyI Leiden,TheNetherlandsMartinA.CheeverI Seattle,WA

SupportiveCareJohnR.WingardI Atlanta,GARaleighBowdenI Seattle,WA

LeukemiasEdwardD.BallI Pittsburgh,PAMichaelL ClearyI Stanford,CA

Non-malignantDisorders:CongenitalandAcquiredRobertsonM.ParkmanI LosAngeles,CARainerF.StorbI Seattle,WA

InformationandApplicationForms:AmericanAssociationfor Cancer

ResearchPublicLedgerBuilding,Suite816150South IndependenceMallWestPhiladelphia,PA 19106-3483215-440-9300 I 215-440-9313 (FAX)e-mail:aacr@aol.com

4' ii.=-.@@!\ ___